Goldman SACHS & Co. LLC, 10% Owner at VIVEVE MEDICAL, INC. (VIVE), sold 46,415 shares at $5.63 ($258K) on 2019-09-25, disclosed to the SEC on 2019-09-30.
Open-market sale of $258k VIVE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.53 | 1,658 | $12K | 4.8% |
| 2 | $5.62 | 10,799 | $61K | 23.5% |
| 3 | $5.63 | 10,799 | $61K | 23.5% |
| 4 | $5.63 | 10,799 | $61K | 23.5% |
| 5 | $5.25 | 7,001 | $37K | 14.2% |
| 6 | $5.02 | 5,359 |
| $27K |
| 10.4% |
| Total | $5.57 avg | 46,415 | $258K | 100% |
| Filing → |
| NCAC | BUY | 2023-03-08 | $0 | — | Filing → |
| NCAC | SELL | 2023-03-08 | $40K | — | Filing → |
| FLYW | SELL | 2022-11-17 | $15.0M | — | Filing → |